Phage Therapy for Drug-Resistant Infections
Author Information
Author(s): Qu Jiayao, Zou Jin, Zhang Jiancong, Qu Jiuxin, Lu Hongzhou
Primary Institution: National Clinical Research Center for Infectious Diseases, Shenzhen Third People’s Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China
Hypothesis
Can inhaled bacteriophage therapy effectively treat extensively drug-resistant Acinetobacter baumannii infections and impact the gut microbiome?
Conclusion
Inhaled bacteriophages can be detected in human blood and may accumulate in the intestines, but prolonged therapy may lead to phage resistance.
Supporting Evidence
- Bacteriophage DNA was detected in blood samples during the second phase of therapy.
- Significant alterations in gut microbiota composition were observed during phage therapy.
- The patient experienced no severe adverse reactions during treatment.
Takeaway
Doctors used a special virus called phages to help a sick lady with a tough infection, and they found that these viruses can travel in her body and change her gut bacteria.
Methodology
The study involved collecting blood, sputum, and fecal samples from a patient undergoing inhaled phage therapy, followed by qPCR and 16S rRNA sequencing to analyze phage distribution and gut microbiota changes.
Limitations
The study is based on a single patient case, limiting the generalizability of the findings.
Participant Demographics
The participant was a 71-year-old female with a history of multiple health issues, including diabetes and severe pneumonia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website